Group 3F: HER2-Low Breast Cancer; HER2+ Breast Cancer; Brain metastasis; Leptomeningeal Disease



Wednesday, Dec 14 6:00 pm – 7:30 pm Eastern Time (US/New York)



Poster #HER2-12

Genomic and transcriptomic landscape of HER2-low breast cancer

Poster author Rani Bansal, M.D. is also the scientist for this session

Poster #PD7-01:

Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: A multicenter retrospective study (ROSET-BM study)

Mentor: Debbie Denardi

Debbie has been screened for breast cancer every 6 months since she was 27 years old due to her family history of breast cancer. Her mother and 3 of her sisters died after a breast cancer diagnosis in the ‘70s. They were all very young (40-45 years old). This family history was reported to every doctor she visited, but no doctor or nurse advised her to get tested for hereditary cancer. Finally, in 2010 when she was 48 years old and after 4 months of a clean mammogram and ultrasound, she was diagnosed with TNBC and a BRCA1 mutation.

Since her diagnosis and lack of education about hereditary cancers, she has been learning as much as she can to educate individuals and families about hereditary cancer. She started her volunteer work with FORCE (Facing Hereditary Cancer Empowered) and has served as a peer support leader in S. Florida since 2012. She also serves as the Treasurer for FORCE’s Board. During the first few years of her advocacy, she attended conferences and continued her local support. In 2018, she had the opportunity to start a new phase of her career and education in advocacy.

Twitter: @debsetu

Scientist: Rani Bansal, M.D.

Rani Bansal, M.D. is currently an Assistant Professor of Medicine and Breast Medical Oncologist at Duke Cancer Institute in Durham, North Carolina. She is also Associate Director of Clinical Research for the Breast Program in Wake County, NC.  Dr. Bansal has a clinical and research interest in breast oncology and is interested in clinical trial development and community outreach. Dr. Bansal completed her Hematology/Oncology Fellowship at Brown University, received her M.D. through the Seven-Year Combined Medical Degree program at Boston University and completed her internal medicine training at Boston Medical Center.

Twitter: @DrRaniBansal